title: [Vitiligo-like lesions in melanoma treated with interleukin-2: 4 cases].
authors.affiliation: Service de Dermatologie, Hôpital Henri-Mondor, Créteil.
authors.forename: P
authors.initials: P
authors.lastname: Wolkenstein
authors.forename: O
authors.initials: O
authors.lastname: Chosidow
authors.forename: J C
authors.initials: JC
authors.lastname: Guillaume
authors.forename: J
authors.initials: J
authors.lastname: Wechsler
authors.forename: M F
authors.initials: MF
authors.lastname: Avril
authors.forename: J
authors.initials: J
authors.lastname: Revuz
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000009:adverse effects*; D007376:Interleukin-2 / Q000627:therapeutic use*; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000556:secondary; D008875:Middle Aged; D014820:Vitiligo / Q000209:etiology*
chemical_list: D007376:Interleukin-2
vernacular_title: Lésions vitiligoides au cours des mélanomes métastasés traités par interleukine-2: 4 observations.